IMC Chicago
GMAB icon

IMC Chicago’s Genmab GMAB Stock Holding History

IMC Chicago’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.08M Buy
148,600
+118,100
+387% +$3.14M ﹤0.01% 2319
2026
Q1 		$818K Buy
30,500
+20,200
+196% +$605K ﹤0.01% 3478
2025
Q4 		$317K Buy
+10,300
New +$321K ﹤0.01% 3770

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

IMC Chicago's GMAB Position: Q2 2026 in Review

IMC Chicago opened a new position in Genmab (GMAB) in Q2 2026: 71,596 shares worth $1.97M. The stake represents ﹤0.01% of the portfolio and ranks #3053 among its holdings. This is a return to the name: IMC Chicago previously reported a position in GMAB as recently as Q4 2025.

IMC Chicago first reported a position in GMAB in Q3 2025 and has held it in 3 quarters since. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • IMC Chicago held 71,596 shares of Genmab worth $1.97M as of Q2 2026.
  • Genmab was a new IMC Chicago position in Q2 2026.
  • Genmab made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3053 holding.
  • IMC Chicago first reported a position in Genmab in Q3 2025 and has held it in 3 quarters since.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.